MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is committed to advancing cancer research. Our extensive portfolio of over 300,000 products supports the development of novel therapies, diagnostics, and prevention strategies. We offer solutions across key areas, including molecular tools, sample preparation, antibodies, cell culture, live cell analysis, biochemicals, and biomarker immunoassays. Cancer research is a multidisciplinary effort, and we provide integrated tools that accelerate progress at every stage—from basic to clinical research. Our molecular tools allow researchers to study cancer’s genetic and molecular foundations, while our high-quality antibodies enable the detection of proteins involved in cancer progression. MilliporeSigma also offers advanced sample preparation technologies for analyzing DNA, RNA, and proteins from tumor samples, and live cell analysis platforms for real-time insights into cellular behaviors and drug responses. Our biomarker immunoassays help identify cancer biomarkers and monitor treatment efficacy, supporting the development of early detection tests and personalized medicine. We are dedicated to empowering researchers with innovative solutions that help advance cancer prevention, detection, and treatment. MilliporeSigma is your trusted partner in tackling cancer biology complexities, accelerating breakthroughs, and realizing a future where cancer is more treatable and preventable. | As a leading science and technology company, we uniquely combine three specialized, innovation-driven businesses: Life Science, Healthcare, and Electronics. We utilize our multi-industry expertise to address a wide spectrum of global challenges. By supplying advanced scientific research and biotechnological manufacturing products, developing therapies for serious diseases, and providing high-performance materials for semiconductors and displays, we contribute to improving health, scientific progress, and technology for people around the world. | MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. We are built to serve you in your drug development journey – as one trusted partner. Whether you need Millipore® CTDMO services, with decades of development, manufacturing, and testing expertise, to deliver a streamlined experience, or standalone industry-leading BioReliance® contract testing services and analytical development, we are built to serve you – to accelerate your milestones and breakthroughs. | MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, leverages over 35 years of CDMO experience and 75 years of contract testing services to redefine the industry CDMO model for today’s dynamic market needs. Our integrated Millipore® CTDMO Services offer expertise in development, manufacturing, contract testing, and technologies from pre-clinical to commercial stages, serving as a single experienced partner to accelerate your milestones and breakthroughs. With extensive experience in mRNA & LNP Formulation, ADC, Small Molecule, Biologics, and Viral Vector, we are dedicated to supporting your drug development journey as a trusted partner. Whether you seek a streamlined experience with a single partner or standalone industry-leading BioReliance® contract testing services and analytical development, we are committed to accelerating your milestones and breakthroughs while forging partnerships aimed at bringing breakthroughs to life to ultimately help patients. 2025 North America Advance Biotech Grant Award Ceremony Join us in the Start-up Stadium at 1:30pm, June 17th, to hear from our finalists and discover who will receive $258,000 in bioprocessing technologies, bioprocessing consulting services, contract testing services, and a full subscription to Emprove® Premium. The next round of applications will open in early 2026. | From the first spark of discovery to full-scale manufacturing, we stand beside you with the products, services, and expertise to help you move with speed and confidence. As a global leader in life science, MilliporeSigma supports innovators across biotech and pharma with 300,000+ products and comprehensive solutions all designed to help you progress from early research through process development, scale-up, and manufacturing. What you can explore with us: • Lab essentials and workflows to keep research moving day to day • Water purification systems for consistent lab performance • Raw and starting materials to support reliable manufacturing • Bioprocessing solutions and customized systems for your unique process needs • Ultrafiltration and downstream technologies to support scalable production • Contract testing and CDMO services to help you advance programs and meet quality requirements Whether you’re advancing a lead candidate, scaling a platform, or strengthening manufacturing readiness, we’ll connect you with experts who can help. | MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany, partners with food safety teams to enable you to improve lab testing efficiencies with reliable products and services that meet ever changing regulations. It is through our collaborations that we can advance the safety and analysis of foods and beverages using trusted brands like Millipore® with microbiology solutions for hygiene, environmental monitoring & pathogen detection, Supelco® analytical solutions for analysis of food contamination and authenticity, Milli-Q® lab water solutions and Sigma Aldrich lab & production materials, including chemicals, inorganics & solvents throughout the supply chain, manufacturing and distribution. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. | MilliporeSigma is the U.S. life science business of Merck KGaA, Darmstadt, Germany. With 19,000 employees and 72 manufacturing sites worldwide, MilliporeSigma’s portfolio spans more than 300,000 products enabling scientific discovery. MilliporeSigma has customers in life science companies, university and government institutions, hospitals and industry. More than 1 million scientists and technologists use its products. The company is committed to solving the toughest problems in life science by collaborating with the global scientific community. For more information, www.emdmillipore.com and www.sigma-aldrich.com.
MILECELL BIOTECHNOLOGY INC.
At MileCell Bio, we are dedicated to advancing life science research by delivering innovative, reliable, and biologically relevant tools that support drug discovery, translational research, and therapeutic development. We understand the complexity of cellular systems and are committed to providing high-quality products that enable consistent, reproducible, and meaningful results. Our core product portfolio focuses on three key areas. Immune cell isolation solutions include primary immune cells such as PBMCs, T cells, NK cells, and other subsets, supported by advanced magnetic MicroBead technologies for positive selection, negative isolation, or cell depletion using PBMCs, whole blood, or buffy coats. Hepatic modeling solutions encompass primary hepatocytes, non-parenchymal cells (NPCs), and subcellular fractions, enabling physiologically relevant liver models for metabolism, toxicity, and disease research. Cell culture and preservation solutions include specialized culture media, CGT-ready cryopreservation media, and optimized kits designed to maintain cell viability and function. Guided by our mission to deliver integrated, primary cell–based solutions, MileCell partners with scientists worldwide to support in vitro research, preclinical studies, and clinical development—helping accelerate the development of safer, more effective therapies. | Primary hepatocytes are indispensable in drug discovery and preclinical research, serving to assess drug metabolism, toxicity, and efficacy. MileCell Bio is dedicated to offering primary hepatocytes, liver microsomes and related products. Our objective is to provide reliable and relevant ADME and toxicology research models for drug discovery, enabling informed decision-making throughout the drug development process. | Founded in 2014, MileCell Biotechnology is a high-tech enterprise dedicated to high-quality human & animal primary cell solutions, providing products & CRO services to pharmaceutical companies and research laboratories, support preclinical research, clinical studies from Phase I to Phase III, and commercialization. We specialize in： •Human Peripheral blood apheresis collection & Human/Animal immune cells isolation/purification services, eg. high-quality PBMCs and other immune cell subsets, including T cells, B cells, NK cells, Monocytes, CD34+ cells and many other cell types; •In vitro hepatic modeling solutions, including Animal hepatocytes, Non-parenchymal cells (NPCs) and Subcellular fractions; •Media/Reagents/Kits for cell culture needs: -Cell Culture Media (Specialty & Supplement varieties). Each product is designed for optimal nutrition and growth of primary cells. -Kryogene™ Cell Freezing Media-CGT (DMF# 040563), a highly efficient, safe, and easy-to-use serum-free cryopreservation media optimized for the special requirements of a variety of cell and gene therapy drugs (CAR-T, CAR-NK, MSC, iPSC, etc). Our Mission & Vision •Mission: Deliver Integrated Solutions Based on Primary Cells •Vision: Drive Pharmaceutical Innovation for a Healthier Future
Meso Scale Diagnostics
Meso Scale Discovery biomarker assays provide a rapid and convenient method for measuring the levels of targets within a single, small-volume sample. The MSD product line offers a diverse menu of assay kits for profiling biomarkers, cell signaling pathways, and other applications.
MedChemExpress
MedChemExpress is one of the leading suppliers for bioactive molecules including bioactive chemical compounds, peptides, recombinant proteins, and inhibitory antibodies. We also provide a comprehensive list of fully customizable screening libraries including various bioactive compound libraries and fragment libraries. We also provide custom synthesis service and CMC/CDMO services.
Lunaphore, a Bio-Techne brand
Bio-Techne’s leading spatial biology brands, Advanced Cell Diagnostics and Lunaphore, are transforming the future of research and precision medicine. From low-plex chromogenic to high-plex fluorescent assays, the scalable platforms and fully automated same-section multiomics workflows bring unmatched performance and flexibility to scientists. Powered by the gold-standard RNAscope™ technology and Lunaphore’s flagship end-to-end fully automated COMET™ product suite, Bio-Techne equip researchers with the right tools to drive breakthroughs and accelerate the journey from discovery to clinic.
LuminoDx
At LuminoDx, we are dedicated to pushing the boundaries of precision medicine, leveraging our experience and expertise. We are paving the way in next-gen liquid biopsy analysis from exosome isolation to high content proteomics (Olink), comprehensive molecular testing and clinical assay development. By leveraging the power of liquid biopsy, we aim to increase precision medicines value for therapeutic development and patient treatment.
LGC Clinical Diagnostics
LGC Clinical Diagnostics is a leading and trusted global manufacturer of Quality Management Tools (QMT) and reagent components. We partner with In Vitro Diagnostics (IVD) and biopharmaceutical developers, clinical research organizations (CROs) and academic institutions in commercialization activities across the entire diagnostic pipeline – from concept and early-stage research, through expedited product development and onwards into routine clinical use. Laboratories and diagnostic professionals across disciplines of clinical chemistry, immunochemistry, serology, molecular diagnostics, and clinical genomics rely on LGC’s products to achieve accurate and reliable diagnostic results.
Leinco Technologies
Leinco Technologies is a leading biotechnology company specializing in the development and manufacture of high-quality antibodies, recombinant proteins, and other life science reagents. With over 30 years of experience, Leinco provides innovative products and custom services to support early-stage research and development in the pharmaceutical, diagnostic, and life sciences industries. Leinco’s comprehensive portfolio includes a wide range of primary and secondary antibodies, in vivo functional grade antibodies, recombinant proteins, and ELISA kits, all produced under stringent quality control standards. Their commitment to excellence is reflected in their ISO 9001:2015 certification and adherence to current Good Manufacturing Practices (cGMP). In addition to their extensive catalog offerings, Leinco provides custom services, such as monoclonal antibody development, protein expression and purification, and assay development, tailored to meet specific research needs. Their experienced scientists and state-of-the-art facilities enable them to deliver high-quality solutions for diverse applications, including drug discovery, diagnostics, and therapeutic development. Leinco Technologies is dedicated to empowering researchers with the tools they need to accelerate scientific discoveries and improve human health. Their commitment to quality, innovation, and customer satisfaction makes them a trusted partner for scientists worldwide.
Leica Biosystems
Leica Biosystems is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. We are committed to delivering Accuracy, Quality and Workflow Efficiencies to help advance diagnostic confidence.
Lanterne Dx
Lanterne Dx (LDX) is a full-service histopathology CRO offering pre-clinical discovery, translational, and clinical biomarker services. LDX specializes in biomarker discovery, development, and validation. Key capabilities include immunohistochemistry (IHC), immunofluorescence (IF), multiplexing, in situ hybridization (ISH), fluorescence in situ hybridization (FISH), and a wide range of microscopic applications. These services are complemented by providing image analysis and slide scanning services in support of all studies. As a CAP and CLIA accredited laboratory our team of MD/DVM pathologists are here to help streamline and accelerate your drug development efforts.